Treatment of trastuzumab-resistant HER2-positive metastatic breast cancer: a case report.

Author: Fan WU ¹ ; Mu Lan CHEN ¹ ; Wei Wei HUANG ¹ ; Jian LIU ¹
Author Information

1. Department of Medical Oncology, Fujian Medical University Cancer Hospital, Fujian Cancer Hospital, Fuzhou 350000, China.
Publication Type:Journal Article
Keywords: Breast neoplasms; Initumumab; Primary drug resistance; Pyrrotinib
MeSH: Humans; Female; Trastuzumab/therapeutic use*; Breast Neoplasms/pathology*; Receptor, ErbB-2; Antibodies, Monoclonal, Humanized/therapeutic use*; Neoplasms, Second Primary; Drug Resistance, Neoplasm
From: Chinese Journal of Oncology 2022;44(12):1390-1392
CountryChina
Language:Chinese